Gianluigi Savarese
Overview
Explore the profile of Gianluigi Savarese including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
312
Citations
5340
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gallone G, Savoca F, Miccoli D, Bohm M, De Ferrari G, Gottlieb S, et al.
JACC Heart Fail
. 2025 Mar;
PMID: 40088236
Background: Patients with heart failure with reduced ejection fraction (HFrEF) have a heightened stroke risk. However, stroke as an endpoint in heart failure trials remains under-reported. Objectives: The authors sought...
2.
Landucci L, Faxen U, Benson L, Rosano G, Dahlstrom U, Lund L, et al.
J Am Heart Assoc
. 2025 Mar;
:e037502.
PMID: 40079278
Background: Sparce data suggest higher mortality in heart failure (HF) with left ventricular ejection fraction (EF) >65% to 70%. We characterized EF distribution, characteristics, and outcomes in patients with HF...
3.
Volterrani M, Halasz G, Adamopoulos S, Agostoni P, Butler J, Coats A, et al.
Eur J Prev Cardiol
. 2025 Mar;
PMID: 40070307
For most patients with chronic, progressive illnesses, maintaining good quality of life (QoL), with preserved functional capacity, is just as crucial as prolonging survival. Patients with heart failure (HF) experience...
4.
Volterrani M, Halasz G, Adamopoulos S, Agostoni P, Butler J, Coats A, et al.
Eur J Heart Fail
. 2025 Mar;
PMID: 40070300
For most patients with chronic, progressive illnesses, maintaining good quality of life (QoL), with preserved functional capacity, is just as crucial as prolonging survival. Patients with heart failure (HF) experience...
5.
6.
Back M, Banach M, Braunschweig F, De Rosa S, Flachskampf F, Kahan T, et al.
Eur Heart J Open
. 2025 Mar;
5(1):oeaf015.
PMID: 40041611
No abstract available.
7.
8.
Skouri H, Girerd N, Monzo L, Petrie M, Bohm M, Adamo M, et al.
Eur J Heart Fail
. 2025 Feb;
PMID: 40012353
Despite major advancements in heart failure (HF) management and guideline recommendations over the past two decades, real-world evidence highlights suboptimal implementation of guideline-directed medical therapy (GDMT) for HF with reduced...
9.
Monzo L, Baudry G, Hernandez G, Denquin O, Savarese G, Lip G, et al.
Eur J Clin Invest
. 2025 Feb;
:e70012.
PMID: 39960169
Background: Atrial fibrillation (AF) and low body weight (BW, <60 kg) are common in patients with heart failure (HF). However, the safety and effectiveness of direct oral anticoagulants (DOACs) in...
10.
Laborante R, Delvinioti A, Tudor A, Lenkowicz J, Iacomini C, Iaconelli A, et al.
BMJ Open
. 2025 Feb;
15(2):e088998.
PMID: 39922597
Objectives: To evaluate the trend of prescription of the four foundational therapies, and their impact on 30-day urgent re-admissions and all-cause death in patients with heart failure and reduced ejection...